GH Research PLC Logo

GH Research PLC

Develops mebufotenin-based therapies for psychiatric and neurological disorders.

GHRS | US

Overview

Corporate Details

ISIN(s):
IE000GID8VI0
LEI:
Country:
United States of America
Address:
JOSHUA DAWSON HOUSE, DUBLIN 2

Description

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to developing therapies for psychiatric and neurological disorders. The company's pipeline is centered on its novel and proprietary mebufotenin (5-MeO-DMT) product candidates. Its lead program, GH001, is an inhaled formulation of mebufotenin being developed for treatment-resistant depression (TRD). Other clinical programs are exploring treatments for bipolar II disorder with a depressive episode and postpartum depression. The company aims to deliver therapies with faster onset of action, durable effects, and improved remission rates. GH Research owns a growing intellectual property portfolio related to mebufotenin's therapeutic applications, formulations, and manufacturing methods.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2024-12-15
English
4.2 MB
2024-10-30
German
1.8 MB
2024-08-14
French
0.5 MB
2024-05-22
English
2.1 MB
2024-03-10
English
3.5 MB
2024-01-15
German
1.2 MB
2023-11-20
English
5.1 MB

Full Filing History Restricted

Access to specific historical documents or filtered results is limited in the Web UI. Request access to the complete dataset.

Automate Your Workflow. Get a real-time feed of all GH Research PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for GH Research PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for GH Research PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Human Stem Cells Institute PJSC Logo
Develops gene therapies, vaccines, medical devices, and genetic testing systems.
Russian Federation
ISKJ
HVIVO PLC Logo
A contract research organization specializing in human challenge trials for biopharma.
United Kingdom
HVO
Hybrigenics SA Logo
Provider of technologies for studying molecular interactions and antibody selection.
France
ALHYG
A contract research organization providing clinical trial services with a focus on oncology.
South Korea
187660
HYUNDAI BIOSCIENCE CO., LTD. Logo
Develops antiviral and anticancer drugs using a proprietary drug delivery system.
South Korea
048410
ICON PLC Logo
Global provider of outsourced development services for pharma, biotech & medical device.
United States of America
ICLR
IGC Pharma, Inc. Logo
Clinical-stage biotech firm developing AI-driven treatments for Alzheimer's disease.
United States of America
IGC
IMCB PJSC Logo
Biotechnology company specializing in personal stem cell banking and genetic testing.
Russian Federation
GEMA
Immuneering Corp Logo
Clinical-stage oncology company developing medicines using computational technology.
United States of America
IMRX
IMMUNIC, INC. Logo
Develops oral small molecule therapies for chronic inflammatory and autoimmune diseases.
United States of America
IMUX

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.